Biomaterial Database

[5-aminosalicylic acid in the long-term treatment of ulcerative colitis]. 1989

N Breuer

Zentrum für Innere Medizin der Universität Essen, Essen 1.

UI	MeSH Term	Description	Entries
D008134	Long-Term Care	Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.	Care, Long-Term,Long Term Care
D008297	Male		Males
D011897	Random Allocation	A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.	Randomization,Allocation, Random
D012008	Recurrence	The return of a sign, symptom, or disease after a remission.	Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D003093	Colitis, Ulcerative	Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.	Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004311	Double-Blind Method	A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.	Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000636	Aminosalicylic Acids	A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.	Acids, Aminosalicylic

Related Publications

N Breuer

5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.

August 1987, The American journal of gastroenterology,

N Breuer

Treatment of ulcerative colitis with 5-aminosalicylic acid.

October 1993, Annals of internal medicine,

N Breuer

Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.

January 1999, Hepato-gastroenterology,

N Breuer

Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.

October 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,

N Breuer

5-aminosalicylic acid based drugs for the treatment of ulcerative colitis.

January 1987, Acta gastro-enterologica Belgica,

N Breuer

[5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].

September 2003, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,

N Breuer

[Ulcerative colitis--colon delivery of 5-aminosalicylic acid].

March 1998, Nihon rinsho. Japanese journal of clinical medicine,

N Breuer

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis.

October 2018, Intestinal research,